As with the brand-name drug, the generic version of sulindac is used to treat pain and inflammation associated with various conditions, such as arthritis. The medicine is available under the name Sulindac tablets and is available in several strengths. Now that the patent for the original drug has expired, several companies manufacture generic sulindac, including Mylan Laboratories, Watson Pharmaceuticals, and Mutual Pharmaceuticals.
Sulindac (Clinoril®) is a medication that has been licensed to treat several conditions. Some sulindac uses include the following:
- Pain relief, such as for pain following a procedure, from muscle strain, or caused by inflammation in a tendon (tendonitis) or bursa (bursitis). It can also be used to treat general pain, such as knee pain, back pain, or foot pain.
- Treatment of arthritis symptoms, including pain, stiffness, and swelling. Sulindac can be used to treat several different types of arthritis, such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout. However, sulindac does not cure these types of arthritis, nor does it change their progression.
Sulindac was originally developed by Merck & Co. The drug has since come off-patent, which means it can now be produced in a generic form.
Generic versions are sold under the name Sulindac tablets and are available in several strengths, including:
- Sulindac 150 mg tablets
- Sulindac 200 mg tablets.
Generic sulindac is currently manufactured by a number of companies, such as:
- Mylan Laboratories
- Watson Pharmaceuticals
- Mutual Pharmaceuticals.